Structures by: Meneghetti F.
Total: 35
C17H25N3O2
C17H25N3O2
Organic Letters (2013) 15, 22 5902
a=11.620(8)Å b=8.989(8)Å c=15.810(8)Å
α=90° β=96.740(10)° γ=90°
C24H29FN2O5
C24H29FN2O5
Organic letters (2015) 17, 18 4468-4471
a=31.820(5)Å b=31.820(5)Å c=6.2030(12)Å
α=90.00° β=90.00° γ=120.00°
C24H34N4O5
C24H34N4O5
Organic & biomolecular chemistry (2018) 16, 4 521-525
a=7.7842(16)Å b=19.387(4)Å c=8.3150(17)Å
α=90° β=106.96(3)° γ=90°
C19H19.5N2.5O3
C19H19.5N2.5O3
Organic & biomolecular chemistry (2018) 16, 4 521-525
a=9.7379(19)Å b=13.134(3)Å c=14.204(3)Å
α=74.40(3)° β=79.76(3)° γ=87.25(3)°
18b
C22H26F3N2O4
Organic & biomolecular chemistry (2015) 13, 48 11633-11644
a=9.7878(8)Å b=10.2150(8)Å c=12.0649(10)Å
α=93.455(2)° β=95.974(2)° γ=109.227(2)°
C25H30N4O5
C25H30N4O5
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=14.548(3)Å b=11.382(2)Å c=14.751(3)Å
α=90° β=103.41(3)° γ=90°
C28H34N4O5
C28H34N4O5
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=9.2923(19)Å b=16.814(3)Å c=9.4272(19)Å
α=90° β=114.86(3)° γ=90°
L6 dimeric Mn complex
C32H36Cl4F3Mn0.5N4O8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=8.3380(17)Å b=27.317(6)Å c=16.519(3)Å
α=90° β=94.12(3)° γ=90°
C30H29F3N4O5
C30H29F3N4O5
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=12.767(3)Å b=13.128(3)Å c=16.753(3)Å
α=90° β=98.22(3)° γ=90°
C30H29F3Mn0N4O6
C30H29F3Mn0N4O6
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=13.127(3)Å b=16.744(3)Å c=25.548(5)Å
α=90° β=90° γ=90°
C30H32N4O6
C30H32N4O6
Dalton transactions (Cambridge, England : 2003) (2020) 49, 18 5965-5973
a=13.089(11)Å b=17.019(14)Å c=25.19(2)Å
α=90° β=90° γ=90°
C52H62Cl8MnN8O10
C52H62Cl8MnN8O10
Dalton transactions (Cambridge, England : 2003) (2020) 49, 38 13420-13429
a=9.967(2)Å b=12.819(3)Å c=13.148(3)Å
α=77.75(3)° β=85.95(3)° γ=69.83(3)°
C32H34Cl7Mn0.5N4O6
C32H34Cl7Mn0.5N4O6
Dalton transactions (Cambridge, England : 2003) (2020) 49, 38 13420-13429
a=12.498(3)Å b=13.003(3)Å c=14.074(3)Å
α=103.95(3)° β=112.74(3)° γ=100.61(3)°
C74H76Cl8MnN10O16
C74H76Cl8MnN10O16
Dalton transactions (Cambridge, England : 2003) (2020) 49, 38 13420-13429
a=12.51240(10)Å b=13.03390(10)Å c=13.95310(10)Å
α=102.7850(10)° β=111.7700(10)° γ=102.8200(10)°
C72H74Cl2MnN10O14
C72H74Cl2MnN10O14
Dalton transactions (Cambridge, England : 2003) (2020) 49, 38 13420-13429
a=12.34(3)Å b=22.76(7)Å c=11.13(2)Å
α=90° β=106.49(14)° γ=90°
C52H62Cl8MnN8O10
C52H62Cl8MnN8O10
Dalton transactions (Cambridge, England : 2003) (2020) 49, 38 13420-13429
a=9.715(5)Å b=12.840(5)Å c=13.069(5)Å
α=77.600(5)° β=85.900(5)° γ=69.600(5)°
C35H36N2O
C35H36N2O
New Journal of Chemistry (2018) 42, 14 12072
a=10.517(5)Å b=11.646(5)Å c=22.808(5)Å
α=90° β=90° γ=90°
C32H32N4O9
C32H32N4O9
New Journal of Chemistry (2018) 42, 14 12072
a=9.764(2)Å b=14.740(3)Å c=24.007(5)Å
α=90° β=90° γ=90°
C30H33Cl2CuN4O8
C30H33Cl2CuN4O8
New Journal of Chemistry (2018) 42, 14 12072
a=19.0262(8)Å b=12.6963(8)Å c=13.6195(8)Å
α=90° β=97.93(2)° γ=90°
C11H14N2O1
C11H14N2O1
Green Chemistry (2018) 20, 17 3912
a=5.8293(3)Å b=9.3602(5)Å c=10.5304(6)Å
α=77.9070(10)° β=80.1830(10)° γ=78.0310(10)°
C14H15ClN2O
C14H15ClN2O
MedChemComm (2013) 4, 8 1181
a=7.929(4)Å b=12.530(4)Å c=12.977(8)Å
α=90° β=90° γ=90°
C16H9ClF3N3O2
C16H9ClF3N3O2
MedChemComm (2012) 3, 5 592
a=11.115(3)Å b=5.008(3)Å c=14.112(5)Å
α=90° β=92.280(10)° γ=90°
Avs-0288
C16H10ClF3N4O2
MedChemComm (2010) 1, 2 156
a=9.064(3)Å b=14.500(3)Å c=12.384(3)Å
α=90.00° β=99.570(10)° γ=90.00°
Md30
C11H11N3O2
MedChemComm (2010) 1, 2 156
a=6.619(2)Å b=20.540(3)Å c=8.364(5)Å
α=90.00° β=103.72(3)° γ=90.00°
Md34
C10H11N3O3S
MedChemComm (2010) 1, 2 156
a=5.589(2)Å b=10.096(2)Å c=10.981(2)Å
α=70.085(9)° β=86.169(9)° γ=74.027(9)°
1,4-Dimethyl-3-phenyl-3H-pyrazolo[3,4-<i>c</i>]isoquinolin-5(4H)-one
C18H15N3O
Acta Crystallographica Section E (2008) 64, 5 o863
a=8.066(2)Å b=19.256(3)Å c=9.270(3)Å
α=90° β=94.66(3)° γ=90°
3-(4-Chlorophenyldiazenyl)-1-methyl-1,4,5,6-tetrahydropyridine
C12H14ClN3
Acta Crystallographica Section E (2008) 64, 7 o1297
a=6.251(2)Å b=8.483(3)Å c=11.824(4)Å
α=77.590(10)° β=78.450(10)° γ=87.01(2)°
6-Chloro-1-(3,5-dimethylphenylsulfonyl)-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C15H13ClN2O3S
Acta Crystallographica Section E (2009) 65, 1 o159
a=12.173(3)Å b=14.036(3)Å c=8.949(2)Å
α=90.00° β=95.77(2)° γ=90.00°
<i>N</i>-(4-Acetyl-3-methyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>-methyl-2-(2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)benzamide
C29H25N5O3
Acta Crystallographica Section E (2013) 69, 10 o1582
a=8.617(4)Å b=20.438(5)Å c=15.038(5)Å
α=90° β=106.27(2)° γ=90°
(<i>E</i>)-2-{[1-(3,11-Dimethyl-4-methylene-10-oxo-1-phenyl-4,5,10,11-tetrahydro-1<i>H</i>-benzo[<i>b</i>]pyrazolo[3,4-<i>f</i>][1,5]diazocin-5-yl)ethylidene]amino}-<i>N</i>-methyl-<i>N</i>-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)benzamide
C40H36N8O2
Acta Crystallographica Section E (2013) 69, 10 o1583
a=13.148(5)Å b=28.640(7)Å c=9.757(4)Å
α=90.00° β=100.19(2)° γ=90.00°
3-(3-Oxo-2,3,4,4a,5,6-hexahydrobenzo[<i>h</i>]cinnolin-2-yl)propionic acid
C15H16N2O3
Acta Crystallographica Section E (2014) 70, 10 o1088-o1089
a=11.217(4)Å b=11.668(4)Å c=12.110(4)Å
α=79.220(10)° β=64.620(10)° γ=68.630(9)°
C22H20Br1N3O4
C22H20Br1N3O4
The Journal of organic chemistry (2016) 81, 5 1877-1884
a=12.5875(4)Å b=11.6251(3)Å c=15.0354(4)Å
α=90° β=109.377(6)° γ=90°
C16H14N2O2S
C16H14N2O2S
The Journal of organic chemistry (2019)
a=5.7417(9)Å b=9.3943(15)Å c=27.095(4)Å
α=90° β=90° γ=90°
C12H17N3O2
C12H17N3O2
The Journal of organic chemistry (2015) 80, 19 9652-9661
a=14.625(3)Å b=6.3084(14)Å c=14.588(3)Å
α=90° β=105.522(5)° γ=90°
C20H24N4O3
C20H24N4O3
Journal of Organic Chemistry (2013) 78, 2600-2610
a=8.491(4)Å b=7.053(5)Å c=15.167(8)Å
α=90° β=99.670(10)° γ=90°